Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Active, not recruiting · NCT05621759 · Registry updated 2026-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD | graft versus host disease, immune system disorder | Active, not recruiting | Phase 2 | 2026-01-29 | NCT05621759 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NYU Langone Health | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NYU Langone Health | New York | United States | 403 |